Aura Biosciences’ $75.6 Million IPO

Goodwin Procter advised Aura Biosciences on the deal.Aura Biosciences, Inc. (Nasdaq: AURA) announced its initial public offering of 5,400,000 shares of common stock at a public offering…

This content is for members only.
Login to Read More Join Now
Martina Bellini

Author: Martina Bellini

This content is for members only.
Login to Read More Join Now